864830-16-0

Basic information

• Product Name: 5-Bromo-2-fluoro-4-methyl-pyridine
• Synonyms: 5-Bromo-2-fluoro-4-methyl-pyridine;2-FLUORO-4-METHYL-5-BROMOPYRIDINE
• CAS NO: 864830-16-0
• Molecular Formula: C₆H₅BrFN
• Molecular Weight: 190.0130032
• Product Categories: Pyridine;Boronic Acid;Variety of halogenated heterocyclic series;Pyridine Series;Fluorine series
• Mol File: 864830-16-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 208.9oC at 760 mmHg
• Flash Point: 80.2oC
• Appearance: Colorless to pale yellow/Liquid
• Density: 1.592g/cm3
• Vapor Pressure: 0.301mmHg at 25°C
• Refractive Index: 1.5300
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: -2.13±0.18(Predicted)
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: 5-Bromo-2-fluoro-4-methyl-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-fluoro-4-methyl-pyridine(864830-16-0)
• EPA Substance Registry System: 5-Bromo-2-fluoro-4-methyl-pyridine(864830-16-0)

Safety Data

• Hazard Codes: T,Xi,Xn
• Statements: 22-37/38-41
• Safety Statements: 26-39
• HazardClass: IRRITANT
• Hazardous Substances Data: 864830-16-0(Hazardous Substances Data)

Usage

Uses

5-Bromo-2-fluoro-4-methylpyridine is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff fields.

InChI:InChI=1/C6H5BrFN/c1-4-2-6(8)9-3-5(4)7/h2-3H,1H3

Upstream product

• 695-34-1 2-Amino-4-methylpyridine 
• 98198-48-2 2-amino-5-bromo-4-methylpyridine 

Downstream Products

• 1073355-13-1 tert-butyl 4-[4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine-1-carboxylate 
• 944582-92-7 tert-butyl 4-(5-bromo-4-methylpyridin-2-yl)piperazine-1-carboxylate 

Relevant articles and documents

CYCLOALKANOPYRIDINE DERIVATIVE

Provided are cycloalkanopyridine derivatives of formula [I]: [wherein the symbols are the same as those stated in the description]. The compounds act as a nociceptin receptor antagonist, and are useful as medicines for diseases associated with a nociceptin receptor, for example, as a reliever against tolerance to a narcotic analgesic; a reliever against dependence on or addiction to a narcotic analgesic; an analgesic enhancer; an antiobesitic or appetite suppressor; a treating or prophylactic agent for cognitive impairment and dementia/amnesia; an agent for treating developmental cognitive abnormality; a remedy for schizophrenia; an agent for treating neurodegenerative diseases; an anti-depressant or treating agent for affective disorder; a treating or prophylactic agent for diabetes insipidus; a treating or prophylactic agent for polyuria; or a remedy for hypotension.